Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1989 Jun;97(2):524–532. doi: 10.1111/j.1476-5381.1989.tb11981.x

Generation of histamine-releasing activity from serum albumin by medium derived from stimulated neutrophils of rat.

D E Cochrane 1, W Boucher 1, R E Carraway 1
PMCID: PMC1854521  PMID: 2474347

Abstract

1. Medium conditioned by rat neutrophils stimulated by N-formyl-methionyl-leucyl-phenylalanine (FMLP) has been found to generate mast cell histamine-releasing activity (HRA) when incubated with bovine serum albumin (BSA). 2. Histamine release increased as the concentration of BSA used to generate HRA was increased from 0.25 to 10 mg ml-1, as the concentration of neurotrophil conditioned medium was increased and as the concentration of FMLP used to stimulate the neutrophils was increased. Histamine release was non-cytotoxic as it was inhibited by energy deprivation or by removal of calcium and it was accompanied by degranulation. 3. HRA was detectable after 30 min of incubation with BSA and its generation continued to increase over the 18 h of our measurements. 4. Generation of HRA was dependent upon the presence of medium from stimulated neutrophils and on the presence of BSA, although plasma could substitute for BSA. Likewise, HRA could be generated from gamma-globulin although to a lesser extent than with albumin. 5. Generation was optimum at acid pH and was inhibited by prior boiling of the neutrophil conditioned medium or by the addition of pepstatin. 6. It is suggested that an enzyme(s) released from the neutrophil during stimulation acts on an albumin-like substrate to generate HRA. It is proposed that HRA is peptide in nature and may be generated during an inflammatory response.

Full text

PDF
524

Images in this article

530Figure 7
on p.530

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bibb P. C., Cochrane D. E., Morel-Laurens N. Loss of quin 2 accompanies degranulation of mast cells. FEBS Lett. 1986 Dec 15;209(2):169–174. doi: 10.1016/0014-5793(86)81105-x. [DOI] [PubMed] [Google Scholar]
  2. Carraway R. E., Mitra S. P., Cochrane D. E. Structure of a biologically active neurotensin-related peptide obtained from pepsin-treated albumin(s). J Biol Chem. 1987 May 5;262(13):5968–5973. [PubMed] [Google Scholar]
  3. Carraway R. E., Mitra S. P., Ferris C. F. Pepsin treatment of mammalian plasma generates immunoreactive and biologically active neurotensin-related peptides in micromolar concentrations. Endocrinology. 1986 Oct;119(4):1519–1526. doi: 10.1210/endo-119-4-1519. [DOI] [PubMed] [Google Scholar]
  4. Carraway R., Cochrane D. E., Lansman J. B., Leeman S. E., Paterson B. M., Welch H. J. Neurotensin stimulates exocytotic histamine secretion from rat mast cells and elevates plasma histamine levels. J Physiol. 1982 Feb;323:403–414. doi: 10.1113/jphysiol.1982.sp014080. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Chandler D., Meusel G., Schumaker E., Stapleton C. FMLP-induced enzyme release from neutrophils: a role for intracellular calcium. Am J Physiol. 1983 Sep;245(3):C196–C202. doi: 10.1152/ajpcell.1983.245.3.C196. [DOI] [PubMed] [Google Scholar]
  6. Coble B. I., Lindroth M., Molin L., Stendahl O. Histamine release from mast cells during phagocytosis and interaction with activated neutrophils. Int Arch Allergy Appl Immunol. 1984;75(1):32–37. doi: 10.1159/000233586. [DOI] [PubMed] [Google Scholar]
  7. Cochrane D. E., Boucher W., Carraway R. E. Mast cell histamine-releasing activity from stimulated rat neutrophils. Int Arch Allergy Appl Immunol. 1988;87(3):269–274. doi: 10.1159/000234684. [DOI] [PubMed] [Google Scholar]
  8. Cochrane D. E., Distel D. L., Lansman J. B., Paterson B. M. Stimulus-secretion coupling in rat mast cells: inactivation of extracellular calcium dependent secretion. J Physiol. 1982 Feb;323:423–435. doi: 10.1113/jphysiol.1982.sp014082. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Cochrane D. E., Douglas W. W. Calcium-induced extrusion of secretory granules (exocytosis) in mast cells exposed to 48-80 or the ionophores A-23187 and X-537A. Proc Natl Acad Sci U S A. 1974 Feb;71(2):408–412. doi: 10.1073/pnas.71.2.408. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Durham S. R., Lee T. H., Cromwell O., Shaw R. J., Merrett T. G., Merrett J., Cooper P., Kay A. B. Immunologic studies in allergen-induced late-phase asthmatic reactions. J Allergy Clin Immunol. 1984 Jul;74(1):49–60. doi: 10.1016/0091-6749(84)90086-1. [DOI] [PubMed] [Google Scholar]
  11. Fantozzi R., Brunelleschi S., Soldaini G. B., Blandina P., Masini E., Raimondi L., Mannaioni P. F. N-Formylmethionyl-leucyl-phenylalanine: Different releasing effects on human neutrophils and rat mast cells. Agents Actions. 1983 Apr;13(2-3):218–221. doi: 10.1007/BF01967336. [DOI] [PubMed] [Google Scholar]
  12. Foreman J. C. The pharmacological control of immediate hypersensitivity. Annu Rev Pharmacol Toxicol. 1981;21:63–81. doi: 10.1146/annurev.pa.21.040181.000431. [DOI] [PubMed] [Google Scholar]
  13. Lemanske R. F., Jr, Kaliner M. Mast cell-dependent late phase reactions. Clin Immunol Rev. 1981;1(4):547–580. [PubMed] [Google Scholar]
  14. Lewis R. A., Austen K. F. The biologically active leukotrienes. Biosynthesis, metabolism, receptors, functions, and pharmacology. J Clin Invest. 1984 Apr;73(4):889–897. doi: 10.1172/JCI111312. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Perez H. D., Ohtani O., Banda D., Ong R., Fukuyama K., Goldstein I. M. Generation of biologically active, complement-(C5) derived peptides by cathepsin H. J Immunol. 1983 Jul;131(1):397–402. [PubMed] [Google Scholar]
  16. Pillai S., Zull J. E. Production of biologically active fragments of parathyroid hormone by isolated Kupffer cells. J Biol Chem. 1986 Nov 15;261(32):14919–14923. [PubMed] [Google Scholar]
  17. Ranadive N. S., Cochrane C. G. Mechanism of histamine release from mast cells by cationic protein (band 2) from neutrophil lysosomes. J Immunol. 1971 Feb;106(2):506–516. [PubMed] [Google Scholar]
  18. Stendahl O., Molin L., Lindroth M. Granulocyte-mediated release of histamine from mast cells. Effect of myeloperoxidase and its inhibition by antiinflammatory sulfone compounds. Int Arch Allergy Appl Immunol. 1983 Mar;70(3):277–284. doi: 10.1159/000233335. [DOI] [PubMed] [Google Scholar]
  19. Theoharides T. C., Douglas W. W. Somatostatin induces histamine secretion from rat peritoneal mast cells. Endocrinology. 1978 May;102(5):1637–1640. doi: 10.1210/endo-102-5-1637. [DOI] [PubMed] [Google Scholar]
  20. Weissmann G., Smolen J. E., Korchak H. M. Release of inflammatory mediators from stimulated neutrophils. N Engl J Med. 1980 Jul 3;303(1):27–34. doi: 10.1056/NEJM198007033030109. [DOI] [PubMed] [Google Scholar]
  21. White M. V., Kaliner M. A. Neutrophils and mast cells. I. Human neutrophil-derived histamine-releasing activity. J Immunol. 1987 Sep 1;139(5):1624–1630. [PubMed] [Google Scholar]
  22. Wintroub B. U., Goetzl E. J., Austen K. F. A neutrophil-dependent pathway for the generation of a neutral peptide mediator: partial characterization of components and control by alpha-1-antitrypsin. J Exp Med. 1974 Sep 1;140(3):812–824. doi: 10.1084/jem.140.3.812. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Zull J. E., Chuang J. Characterization of parathyroid hormone fragments produced by cathepsin D. J Biol Chem. 1985 Feb 10;260(3):1608–1613. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES